Mantian Mi Selected Research

ampelopsin

1/2016	Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway.
11/2015	Ampelopsin protects endothelial cells from hyperglycemia-induced oxidative damage by inducing autophagy via the AMPK signaling pathway.
10/2014	Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress.
8/2014	Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway.
1/2014	Ampelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mantian Mi Research Topics

Disease

12	Insulin Resistance 01/2022 - 01/2014
10	Neoplasms (Cancer) 09/2017 - 09/2008
10	Breast Neoplasms (Breast Cancer) 09/2017 - 09/2008
9	Inflammation (Inflammations) 01/2022 - 11/2011
9	Hypoxia (Hypoxemia) 01/2021 - 07/2009
6	Obesity 01/2022 - 01/2017
6	Non-alcoholic Fatty Liver Disease 03/2020 - 03/2015
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 07/2009
5	Body Weight (Weight, Body) 01/2020 - 08/2016
4	Hyperglycemia 01/2022 - 11/2015
4	Fatigue 01/2021 - 01/2014
4	Atherosclerosis 01/2019 - 12/2009
4	Carcinogenesis 09/2017 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 10/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 09/2008
3	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2015 - 03/2008
2	Alcoholic Fatty Liver 01/2020 - 01/2019
2	Wounds and Injuries (Trauma) 01/2019 - 11/2014
2	Muscular Atrophy (Muscle Atrophy) 01/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 08/2016
1	Fibrosis (Cirrhosis) 06/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Glucose Intolerance 01/2020
1	Dysbiosis 01/2019

Drug/Important Bio-Agent (IBA)

12	dihydromyricetinIBA 01/2022 - 07/2015
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
6	LipidsIBA 01/2020 - 11/2011
5	Sirtuin 3IBA 01/2022 - 12/2016
5	ResveratrolIBA 03/2020 - 01/2014
5	FlavonoidsIBA 10/2019 - 09/2008
5	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2015
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2014
5	ampelopsinIBA 01/2016 - 01/2014
5	Taurine FDA Link 10/2010 - 03/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2017
4	PalmitatesIBA 03/2020 - 01/2016
4	EquolIBA 01/2020 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 12/2010
4	3,6-dihydroxyflavoneIBA 09/2017 - 12/2010
4	Insulin (Novolin)FDA Link 08/2016 - 07/2009
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2021 - 03/2015
3	Therapeutic UsesIBA 03/2020 - 09/2015
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 08/2016
3	Messenger RNA (mRNA)IBA 01/2020 - 04/2002
3	Capsaicin (Zostrix)FDA Link 12/2019 - 01/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2018 - 11/2014
3	Adenosine Monophosphate (AMP)IBA 10/2014 - 01/2014
2	Interleukin-22 (IL-22)IBA 01/2022 - 01/2020
2	Liposomes (Liposome)IBA 01/2022 - 09/2008
2	Alanine Transaminase (SGPT)IBA 06/2021 - 03/2015
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 01/2020
2	NitrogenIBA 01/2021 - 01/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2020
2	AcidsIBA 03/2020 - 01/2019
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 12/2019
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 03/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 12/2009
2	AMP-Activated Protein KinasesIBA 01/2017 - 11/2015
2	C-PeptideIBA 08/2016 - 03/2015
2	ApolipoproteinsIBA 01/2016 - 09/2015
2	3-hydroxyflavoneIBA 11/2015 - 10/2014
2	Pharmaceutical PreparationsIBA 11/2015 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 12/2009
2	fibroblast growth factor 21IBA 09/2015 - 03/2015
2	LDL CholesterolIBA 09/2015 - 03/2015
2	Keratin-18 (Keratin 18)IBA 09/2015 - 03/2015
2	myricetinIBA 01/2015 - 01/2015
2	AntioxidantsIBA 01/2014 - 01/2013
2	Glutamic Acid (Glutamate)FDA Link 01/2010 - 03/2008
1	EndotoxinsIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	CollagenIBA 06/2021
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 06/2021
1	Tissue Inhibitor of MetalloproteinasesIBA 06/2021
1	Carbon Tetrachloride (Tetrachloromethane)IBA 06/2021
1	DesminIBA 06/2021
1	Volatile Fatty AcidsIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	iodopravadoline (AM 630)IBA 01/2020
1	Liver GlycogenIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Sirtuin 1IBA 01/2020
1	EndocannabinoidsIBA 01/2020
1	GlycogenIBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 10/2019
1	Palmitic Acid (Hexadecanoic Acid)IBA 10/2019
1	Butyric Acid (Butanoic Acid)IBA 01/2019
1	A-factor (Streptomyces)IBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	GlucocorticoidsIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	CarcinogensIBA 09/2017
1	MethyltransferasesIBA 09/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017

Therapy/Procedure

2	Transplantation 01/2021 - 01/2017